Dr Bishal Gyawali speaks to ecancer following ESMO 2021 about the highlights from this year’s conference.
Dr Gyawali discusses presentations that cover several areas of cancer including genitourinary, urothelial, breast, cervical, head and neck, GI and lung, including adjuvant immunotherapy, negative and single-arm trials.
Some of the trials he refers to are:
STAMPEDE, PEACE-1, VESPER, BrighTNess, DESTINY, TULIP, KEYNOTE-355, KEYNOTE-826, KEYNOTE-716, IMpower010, AtezoTRIBE, NEONAX, Checkmate 649, and DESTINY-Lung01.
|Metastatic Breast Cancer|
|Adjuvant Immunotherapy Trials|
|Head and Neck Cancers|
|Final results of CheckMate 651|
All opinions expressed in this video are the speakers own and do not reflect that of any institution.